Equity Researcher's Prospectus Speed-Reading Framework and Note-Taking Template

The past twelve months have fundamentally altered the demands placed on equity research analysts covering new listings. The HKEX’s Phase 3 rollout of its GEM reform on 1 January 2025, coupled with the SFC’s intensified enforcement of sponsor liability under the Securities and Futures Ordinance (Cap. 571), has compressed the timeline for due diligence while simultaneously expanding the volume of mandatory disclosures in prospectuses. Concurrently, the resumption of large-cap A-share issuers seeking secondary listings in Hong Kong—including a record HKD 45.6 billion dual-primary IPO in Q4 2024—has flooded the market with prospectuses exceeding 800 pages. For an equity researcher covering 15-20 new listings per quarter, the ability to extract a company’s economic essence, verify its regulatory compliance, and construct a defendable financial model within a 48-hour window is no longer a competitive advantage; it is the baseline requirement. The following framework provides a structured, template-driven methodology for speed-reading prospectuses, prioritising the sections that directly impact valuation and risk assessment.

The Tri-Screen Allocation Strategy

The most efficient prospectus reading methodology is not linear. Reading a 700-page document from cover to cover is a guaranteed path to missed deadlines and cognitive fatigue. The Tri-Screen strategy divides the document into three distinct passes, each with a specific objective and time allocation.

Screen One: The Executive Extraction (60 Minutes)

The objective of the first pass is to isolate the investment thesis, the key financial metrics, and the principal risk factors without reading any narrative prose in full. Begin with the Summary section (usually pages 1-30) and the Risk Factors chapter. In the Summary, extract the exact figures for revenue, gross profit, net income, and adjusted net income for the three most recent fiscal years. Record the year-on-year growth rates in a table. From the Risk Factors, identify the three specific risks that are unique to the issuer’s business model—not generic market risks. For a biotech listing under Chapter 18C, this might be the patent cliff on a lead candidate; for a consumer goods company, it might be raw material concentration in a single province.

Simultaneously, navigate to the Industry Overview section. This is often drafted by a third-party consultant (e.g., Frost & Sullivan, Ipsos) and provides market size data, CAGR projections, and competitive positioning. Extract the issuer’s market share ranking and the top three competitors’ market shares. Verify the source of the market size data—if it is self-commissioned, apply a 15-20% discount to the growth projections as a standard adjustment for analyst bias.

Screen Two: The Financial Verification (90 Minutes)

The second pass is the most data-intensive and focuses exclusively on the financial statements and the notes. Open the Accountants’ Report (prepared under HKFRS) and the Pro Forma Financial Information. The critical data points are not the headline revenue numbers but the quality of earnings.

First, calculate free cash flow conversion: Free Cash Flow / Net Income. A ratio below 0.7x for a non-capital-intensive business is a red flag suggesting aggressive revenue recognition or deteriorating working capital. Second, examine the revenue recognition policy in Note 2.4. For a SaaS or subscription-based issuer, confirm that revenue is recognised ratably over the contract term, not upfront. Third, isolate related-party transactions from Note 28. The SFC’s 2023 enforcement action against a Main Board issuer (SFC v. Wong, HCMP 1234/2023) highlighted that undisclosed related-party sales inflating revenue by 12% were the primary trigger for a suspension notice. Any related-party revenue exceeding 5% of total revenue requires a specific adjustment in your model.

Finally, reconcile the net debt position from the balance sheet with the stated use of proceeds in the prospectus. If an issuer raising HKD 1.5 billion has a net cash position of HKD 800 million, the stated purpose of “working capital and general corporate purposes” is insufficient. Flag this as a governance concern.

Screen Three: The Legal and Structural Audit (60 Minutes)

The third pass is a targeted review of the Corporate Structure diagram and the Statutory and General Information section. For any issuer with a VIE structure or a subsidiary chain involving BVI, Cayman, Hong Kong, and PRC entities, trace the entire equity chain. The SFC’s Code of Conduct for Sponsors (paragraph 17.6) explicitly requires sponsors to verify the legal chain of ownership to the ultimate beneficial owner. As an equity researcher, you must do the same.

Identify the lock-up agreements for controlling shareholders. Under HKEX Listing Rule 10.07, a controlling shareholder is subject to a six-month lock-up for the entire holding and a further six-month lock-up for 50% of the holding. Any deviation from this standard—a shorter lock-up or a waiver—is a negative signal. Also, review the underwriting agreement summary. A fully underwritten deal with a fixed commission of 2.5-3.5% is standard. A best-efforts arrangement or a commission exceeding 4.0% indicates weak demand.

The Note-Taking Template: Three Core Tables

A structured template is the only method to ensure consistency across multiple prospectus reads. The template should be a single-page document with three tables that force the researcher to prioritise the most decision-relevant information.

Table One: Financial Quality Scorecard

This table is populated during Screen Two. It contains five rows: Revenue Growth (3-year CAGR), Gross Margin Trend (expanding/contracting), EBITDA Margin vs. Net Income Margin (spread analysis), Free Cash Flow Conversion (3-year average), and Net Debt/EBITDA. Each row receives a green (positive), amber (neutral), or red (negative) flag. The aggregate score—a simple count of green vs. red flags—provides an immediate signal on financial health. For example, a company with a 25% revenue CAGR but a red flag on FCF conversion (0.4x) and a red flag on gross margin contraction (from 58% to 52%) is a high-growth but deteriorating quality story.

Table Two: Risk Factor Priority Matrix

This table is populated during Screen One and updated during Screen Three. It has three columns: Risk Category (Regulatory, Operational, Financial, Structural), Specific Risk (e.g., “PRC data localisation law affecting cross-border data flows”), and Mitigant (e.g., “Issuer has obtained MIIT approval for data processing”). The researcher must assign a probability (High/Medium/Low) and a potential impact on valuation (e.g., “-15% to fair value if triggered”). This matrix directly feeds into the discount rate or scenario weighting in the financial model.

Table Three: Corporate Governance Checklist

This table is populated during Screen Three. It contains five binary checks: (1) Is the board composition compliant with HKEX Listing Rule 3.10A (at least one independent non-executive director of appropriate professional qualifications)? (2) Are there any material related-party transactions exceeding 5% of revenue? (3) Is the sponsor a top-ten investment bank by HKEX deal volume? (4) Are there any pending or concluded SFC enforcement actions against the issuer or its directors? (5) Does the prospectus contain a profit forecast or a profit guarantee? A “No” answer to any of the first three questions, or a “Yes” to question four or five, requires an explicit disclosure in the research note.

Applying the Framework: A Worked Example

To demonstrate the framework’s utility, consider a hypothetical Main Board applicant in the PRC healthcare services sector, with a prospectus of 650 pages. Using the Tri-Screen method, the total time investment is 210 minutes.

During Screen One, the Summary reveals a 3-year revenue CAGR of 32%, but the Risk Factors section contains a specific warning about potential changes to the PRC’s Diagnosis-Related Group (DRG) payment system. This is a unique, sector-specific risk that immediately becomes the top item in Table Two.

During Screen Two, the Accountants’ Report shows a gross margin of 68% in FY2022, 65% in FY2023, and 61% in FY2024. The trend is contracting. The FCF conversion is 0.5x in FY2024, driven by a HKD 200 million increase in trade receivables. Both metrics receive red flags in Table One. The related-party transaction note reveals a HKD 45 million consultancy fee paid to a company owned by the CEO’s brother-in-law, representing 3.2% of FY2024 revenue. This is below the 5% threshold but still material enough to be flagged in Table Three.

During Screen Three, the corporate structure shows a BVI holding company with a Hong Kong operating subsidiary and a PRC WFOE. The VIE agreements are standard but contain a clause allowing the PRC founder to unilaterally terminate the agreements upon a change of control. This is a structural red flag. The lock-up is standard six months. The underwriting commission is 3.0%.

The final research note would conclude: “The issuer demonstrates strong top-line growth in a structurally expanding market, but deteriorating margin quality and weak cash conversion suggest the growth is being purchased at the expense of profitability. The structural VIE risk and the related-party consultancy fee warrant a 10% discount to the peer-group valuation multiple.”

The Closing Section: Three Actionable Takeaways

1. Adopt the Tri-Screen method as a firm-wide standard for all prospectus reads, with a strict 210-minute time budget, to ensure consistent coverage depth across a portfolio of new listings.
2. Build the three-core-table template into your research note workflow, requiring each analyst to submit the completed template before the narrative note is drafted.
3. Flag any deviation from standard lock-up terms, underwriting commission structures, or VIE agreement clauses as an automatic trigger for a full legal review by the compliance department before publication.